First Manhattan’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Buy
6,746
+906
+16% +$86.8K ﹤0.01% 530
2025
Q4
$565K Buy
5,840
+1,514
+35% +$147K ﹤0.01% 533
2025
Q3
$415K Buy
4,326
+235
+6% +$21.6K ﹤0.01% 578
2025
Q2
$360K Sell
4,091
-1,095
-21% -$92.9K ﹤0.01% 590
2025
Q1
$470K Sell
5,186
-178
-3% -$15.9K ﹤0.01% 514
2024
Q4
$432K Sell
5,364
-63
-1% -$5.45K ﹤0.01% 532
2024
Q3
$492K Buy
5,427
+130
+2% +$10.9K ﹤0.01% 491
2024
Q2
$421K Buy
5,297
+133
+3% +$10.9K ﹤0.01% 503
2024
Q1
$450K Sell
5,164
-5
-0.1% -$427 ﹤0.01% 511
2023
Q4
$426K Sell
5,169
-84
-2% -$6.4K ﹤0.01% 509
2023
Q3
$412K Buy
5,253
+160
+3% +$13.4K ﹤0.01% 523
2023
Q2
$449K Sell
5,093
-1,373
-21% -$118K ﹤0.01% 510
2023
Q1
$521K Buy
6,466
+575
+10% +$46.9K ﹤0.01% 500
2022
Q4
$458K Buy
5,891
+2,636
+81% +$214K ﹤0.01% 530
2022
Q3
$262K Buy
3,255
+94
+3% +$8.45K ﹤0.01% 639
2022
Q2
$283K Hold
3,161
﹤0.01% 646
2022
Q1
$350K Sell
3,161
-82
-3% -$8.66K ﹤0.01% 653
2021
Q4
$335K Sell
3,243
-3,535
-52% -$409K ﹤0.01% 641
2021
Q3
$849K Sell
6,778
-22
-0.3% -$2.85K ﹤0.01% 451
2021
Q2
$844K Buy
6,800
+37
+0.5% +$4.65K ﹤0.01% 454
2021
Q1
$798K Hold
6,763
﹤0.01% 448
2020
Q4
$792K Sell
6,763
-54
-0.8% -$5.95K ﹤0.01% 434
2020
Q3
$708K Sell
6,817
-169
-2% -$17K ﹤0.01% 432
2020
Q2
$640K Buy
6,986
+317
+5% +$30.4K ﹤0.01% 447
2020
Q1
$601K Buy
6,669
+1,135
+21% +$121K ﹤0.01% 438
2019
Q4
$627K Sell
5,534
-120
-2% -$13.2K ﹤0.01% 490
2019
Q3
$614K Buy
5,654
+1,199
+27% +$125K ﹤0.01% 492
2019
Q2
$433K Buy
4,455
+45
+1% +$4.11K ﹤0.01% 568
2019
Q1
$401K Sell
4,410
-189,382
-98% -$17M ﹤0.01% 590
2018
Q4
$17.6M Sell
193,792
-500
-0.3% -$46.7K 0.11% 113
2018
Q3
$19.1M Sell
194,292
-85,536
-31% -$7.91M 0.1% 126
2018
Q2
$24M Sell
279,828
-1,543
-0.5% -$129K 0.14% 108
2018
Q1
$22.6M Sell
281,371
-586
-0.2% -$48.3K 0.13% 119
2017
Q4
$22.8M Sell
281,957
-16,614
-6% -$1.33M 0.12% 121
2017
Q3
$23.2M Sell
298,571
-2,198
-0.7% -$182K 0.13% 120
2017
Q2
$26.7M Sell
300,769
-50,850
-14% -$4.29M 0.16% 114
2017
Q1
$28.3M Sell
351,619
-6,292
-2% -$491K 0.17% 101
2016
Q4
$25.5M Sell
357,911
-130,977
-27% -$10.3M 0.16% 107
2016
Q3
$42.2M Sell
488,888
-8,597
-2% -$749K 0.26% 75
2016
Q2
$43.2M Buy
497,485
+18,918
+4% +$1.53M 0.27% 70
2016
Q1
$35.9M Sell
478,567
-28,829
-6% -$2.17M 0.22% 74
2015
Q4
$39M Sell
507,396
-322,661
-39% -$24.3M 0.24% 72
2015
Q3
$55.6M Sell
830,057
-1,318
-0.2% -$97.1K 0.36% 50
2015
Q2
$61.6M Sell
831,375
-6,590
-0.8% -$503K 0.36% 51
2015
Q1
$65.4M Buy
837,965
+621,272
+287% +$47.1M 0.38% 52
2014
Q4
$15.6M Buy
216,693
+7,671
+4% +$533K 0.09% 144
2014
Q3
$12.9M Sell
209,022
-628,820
-75% -$40M 0.08% 154
2014
Q2
$53.4M Sell
837,842
-9,635
-1% -$585K 0.34% 64
2014
Q1
$52.2M Sell
847,477
-257,298
-23% -$15M 0.34% 62
2013
Q4
$63.4M Sell
1,104,775
-100
-0% -$5.67K 0.42% 53
2013
Q3
$58.8M Sell
1,104,875
-637
-0.1% -$34.3K 0.41% 52
2013
Q2
$61.2M Buy
+1,105,512
New +$54.6M 0.42% 52

Other funds holding MDT

First Manhattan's MDT Position: Q1 2026 in Review

First Manhattan increased its Medtronic (MDT) stake by 16% in Q1 2026, buying an estimated $86.8K and bringing the position to 6,746 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

First Manhattan first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $65.4M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • First Manhattan held 6,746 shares of Medtronic worth $589K as of Q1 2026.
  • First Manhattan bought 906 Medtronic shares in Q1 2026, an estimated $86.8K.
  • Medtronic made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #530 holding.
  • First Manhattan first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's Medtronic position peaked at $65.4M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.